Camleton-MHFP (Camethon)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCamphor + Chlorobutanol + Eucalyptus leaf-shaped oil + [Levomentol]Camphor + Chlorobutanol + Eucalyptus leaf-shaped oil + [Levomentol]
Similar drugsTo uncover
  • Cameton
    spray locally 
    MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC     Russia
  • Cameton
    aerosol locally 
    PHARMSTANDART-FORESTRY, OJSC     Russia
  • Cameton
    aerosol locally 
    MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC     Russia
  • Cameton
    aerosol locally 
    ALVILS, LTD.     Russia
  • Camleton-MHFP
    aerosol locally 
    MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC     Russia
    • Dosage form: & nbspaerosol for topical use
    Composition:

    In 1 bottle for 15 g of the drug / for 30 g of the drug contains:

    Active substances:

    chlorobutanol hemihydrate (chlorobutanol) (in terms of 100% chlorobutanol) - 0.05 g / OD g; camphor synthetic (camphor) (in terms of 100% substance) - 0.05 g / 0.1 g; L-menthol (levomenthol) (in terms of 100% substance) - 0.05 g / 0.1 g; eucalyptus oil - 0.05 g / 0.1 g.

    Excipients:

    isopropyl myristate 4.8 g (9.6 g; propellant HFC-134a (1,1,1,2-tetrafluoroethane) 10.0 g / 20.0 g.

    Description:Oily liquid, which is under the pressure of a propellant in an aerosol container with a metering valve. The preparation, when leaving the balloon, is sprayed in the form of an aerosol jet, which is a liquid particle with a characteristic odor dispersed in the gaseous medium.
    Pharmacotherapeutic group:Antiseptic
    ATX: & nbsp

    R.02.A   Drugs for the treatment of throat diseases

    Pharmacodynamics:

    Cameton-MCPA is a combined preparation for topical application, the effect of which is determined by its constituent components. Has a local anti-inflammatory, antiseptic and moderate "distracting" effect.

    Chlorobutanol with local application has a moderate "distracting", anti-inflammatory and antiseptic effect.

    Camphor has an irritating and partly antiseptic effect, increases blood flow at the site of application.

    Levomenthol has a local irritating effect, accompanied by a feeling of cold. An irritating (distracting) effect helps to eliminate pain. It also has weak antiseptic properties.

    Eucalyptus oil has a stimulating effect on the receptors of the mucous membranes, it also has a weak local anti-inflammatory and antiseptic activity.

    The combination of these pharmacological properties provides a comprehensive pathogenetic therapy for inflammatory diseases of the upper respiratory tract.

    Pharmacokinetics:
    Due to low systemic absorption, there is no data on the pharmacokinetics of the drug.
    Indications:
    In the complex therapy of infectious and inflammatory diseases of the ENT organs (rhinitis, tonsillitis, pharyngitis, laryngitis).
    Contraindications:
    Hypersensitivity to the components of the drug, children under 5 years.
    Pregnancy and lactation:

    There is no sufficient experience on the use of the drug during pregnancy and breastfeeding. The use of the drug during pregnancy is possible if the expected benefit for the mother exceeds the potential risk to the fetus. Consultation of the doctor is necessary.

    Due to low systemic absorption of the components that make up the drug, it is possible to use it during breastfeeding. Consultation of the doctor is necessary.

    Dosing and Administration:

    Locally.

    Remove the protective cap from the sprayer before use. When using the balloon, keep it upright. After applying the drug to the nebulizer, wear a protective cap.

    To treat rhinitis, you should first cleanse the nose of mucus, then inject the sprayer to a depth of 0.5 cm.Spray the drug should be carried out at the inspiratory phase by pressing the base of the nebulizer with the thumb and forefinger from top to bottom until it stops. For one application in adults and children over 15 years of age, 2-3 sprays are administered to each nostril, in children aged 5 to 12 years - 1 spraying, in children from 12 to 15 years - 1-2 sprays. The frequency of application is 3-4 times a day. The course of treatment is 7-10 days.

    In the treatment of inflammatory diseases of the pharynx and larynx (tonsillitis, pharyngitis, laryngitis), the spray nozzle is injected into the oral cavity. The drug should be used after eating, after rinsing the mouth with warm boiled water. Spray the drug in this case, regardless of the phase of inspiration and expiration. For one application in adults and children over 15 years of age, 2-4 sprays are performed to the right and left, in children from 12 to 15 years - 1-2 sprays, in children aged 5 to 12 years - 1 spraying. The frequency of application is 3-4 times a day. The course of treatment is 7-10 days.

    Side effects:
    Allergic reactions in the form of skin rashes are possible. With the use of the drug, sensations of slight burning and tingling are possible.
    Overdose:

    Signs of acute intoxication when ingested: nausea, vomiting, stomach pain. The victim should immediately consult a doctor.

    Measures to help with overdose: removing the drug from the stomach and intestines (gastric lavage, artificial vomiting, the use of salt laxatives, enema, the use of intestinal adsorbents - activated charcoal), symptomatic treatment.

    Interaction:Clinically significant interaction of the drug with drugs of other groups was not revealed.
    Special instructions:

    When spraying in the nasal cavity, do not tip your head and turn the bottle upside down. It is not recommended to use the same ballon several individuals to avoid the spread of infection. When spraying the drug, avoid contact with eyes. The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Do not open the container. Do not spray near fire. Protect from falls and shocks. Do not freeze. Keep away from heating system and direct sunlight.

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:
    Aerosol for topical application.
    Packaging:

    For 15 g or 30 grams in cylinders, aluminum monoblock, sealed by a metering valve and equipped with a sprayer with a protective cap.

    The cylinder, sealed with a metering valve, equipped with a sprayer with a protective cap, together with the instruction for use, is placed in a pack of cardboard.

    Storage conditions:

    At a temperature of 2 to 30 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001714
    Date of registration:02.07.2012
    Expiration Date:02.07.2017
    The owner of the registration certificate:MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspMOSHIMFARM PREPARATES them. NA Semashko OJSC MOSHIMFARM PREPARATES them. NA Semashko OJSC Russia
    Information update date: & nbsp23.11.2017
    Illustrated instructions
      Instructions
      Up